Cargando…

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Background: Carbapenems (ertapenem, imipenem, meropenem) are used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB), even if the published evidence is limited, particularly when it is otherwise difficult to identify the recommended four active drugs to be inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotgiu, Giovanni, D’Ambrosio, Lia, Centis, Rosella, Tiberi, Simon, Esposito, Susanna, Dore, Simone, Spanevello, Antonio, Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813232/ https://www.ncbi.nlm.nih.gov/pubmed/26985890 http://dx.doi.org/10.3390/ijms17030373

Ejemplares similares

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Recent developments in the diagnosis and management of tuberculosis
por: Sulis, Giorgia, et al.
Publicado: (2016)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium
por: D’Ambrosio, Lia, et al.
Publicado: (2017)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

The battle against colistin-resistant E. coli and the need for a one health approach
por: Danaei, Bardia, et al.
Publicado: (2023)

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
por: Nalunjogi, Joanitah, et al.
Publicado: (2023)

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
por: Tadolini, Marina, et al.
Publicado: (2016)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
por: Arbex, Marcos Abdo, et al.
Publicado: (2015)

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
por: Migliori, Giovanni Battista, et al.
Publicado: (2012)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia
por: Zampogna, Elisabetta, et al.
Publicado: (2021)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
por: Amicosante, Massimo, et al.
Publicado: (2017)

Global TB Network: working together to eliminate tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022)

The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2023)

Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature
por: Esposito, Susanna, et al.
Publicado: (2016)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia
por: Visca, Dina, et al.
Publicado: (2022)

Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
por: Visca, D., et al.
Publicado: (2021)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
por: D’Ambrosio, Lia, et al.
Publicado: (2021)

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvgql2vktla600fkttv73f06kl